NCT00484458

Brief Summary

The purpose of this study is to demonstrate that the Wallis System (interspinous process implant) is equivalent to total disc replacement (TDR) for the treatment of mild to moderate degenerative disc disease (DDD) of the lumbar spine at the L4-L5 level. This study will assess the safety and efficacy of the Wallis® System compared to commercially available lumbar TDR with respect to individual subject success rates at 24 months postoperative follow-up. Study participants will receive all study related test articles and surgical procedures at no charge. Please scroll down to the "Locations" section to find a doctor in your area that is participating in this study. If you are interested in participating in this study and do not see a doctor in your area, please contact Jose Naveira at jose.naveira@abbottspine.com

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
340

participants targeted

Target at P50-P75 for phase_3 low-back-pain

Timeline
Completed

Started Jan 2007

Longer than P75 for phase_3 low-back-pain

Geographic Reach
1 country

11 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2007

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

June 7, 2007

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 11, 2007

Completed
6.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2013

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2014

Completed
Last Updated

October 4, 2011

Status Verified

October 1, 2011

Enrollment Period

6.8 years

First QC Date

June 7, 2007

Last Update Submit

October 3, 2011

Conditions

Keywords

Degenerative Disc DiseaseTotal Disc Replacement

Outcome Measures

Primary Outcomes (1)

  • Non-inferior to commercially available lumber TDR after 24 months.

    24 months

Study Arms (2)

1

EXPERIMENTAL

Wallis Stabilization System

Device: Interspinous process and dynamic stabilization (Wallis System)

2

ACTIVE COMPARATOR

Total Disc Replacement

Device: Total Disc Replacement

Interventions

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age 18-60 (inclusive) and skeletally mature.
  • Diagnosis of mild to moderate DDD at L4-L5 as confirmed by radiography.
  • Minimum of six months of failed conservative treatment.
  • Pre-operative visual analog (VAS) low back pain score ≥ 40, on a scale of 100mm, with low back pain greater than left or right leg pain.
  • Preoperative baseline Oswestry Disability Index (ODI) score of ≥ 40 on a 100 point scale.
  • Physically and mentally able to comply with the protocol, including ability to read and complete required forms, and willing and able to adhere to the follow-up requirements of the protocol.
  • Voluntarily signs the patient informed consent form.
  • Patient is a surgical candidate for an anterior approach to the lumbar spine (\< 3 abdominal surgeries).

You may not qualify if:

  • The investigator believes that the L1-L2, L2-L3, L3-L4, or L5-S1 level is symptomatic based upon objective evidence, e.g., radiograph, MRI, or discography.
  • Evidence of a prior fracture or trauma to the vertebral bodies at the affected level and/or the spinous processes at the L4-L5 or adjacent levels.
  • Osteoporosis or osteopenia or metabolic bone disease as confirmed by DEXA scan (T score \< -1.0). Female subjects older than 45 years of age (or post-menopausal women, history of oophorectomy, or family history of osteoporosis) and male subjects older than 55 years will undergo a pre-operative, dual energy x-ray absorptiometry (DEXA) of the lumbar spine. The DEXA will be used to identify subjects with an indication of osteoporosis, osteopenia or metabolic bone disease. Subjects with a T-score of less than -1.0 will be excluded from the study.
  • Congenital lumbar spinal stenosis.
  • Bony lumbar stenosis.
  • Extreme obesity, as defined by National Institutes of Health (NIH) Clinical Guidelines Body Mass Index (BMI \> 40kg/m2).
  • A history of any surgical procedure intended to remove or alter the disc (e.g. discectomy, intradiscal electrothermal therapy (IDET) or enzymes), decompress (laminectomy) or fuse, either the index or adjacent levels.
  • Prior participation in study of any investigational spinal implant or investigational spinal treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (11)

Spine Source

Beverly Hills, California, 90212, United States

Location

Core Orthopaedic Medical Center

Encinitas, California, 92024, United States

Location

Boulder Neurosurgical Associates

Boulder, Colorado, 80504, United States

Location

Denver Spine

Greenwood Village, Colorado, 80111, United States

Location

Illinois Bone & Joint Institute

Morton Grove, Illinois, 60053, United States

Location

Fort Wayne Orthopaedics

Fort Wayne, Indiana, 46804, United States

Location

Medical University of South Carolina

Charleston, North Carolina, 29425, United States

Location

Triangle Orthopaedic Associates, P.A.

Durham, North Carolina, 27302, United States

Location

Lehigh Valley Hospital

Allentown, Pennsylvania, 18103, United States

Location

University of Utah-Dept. of Neurosurgery-Dept. of Orthopedic Surgery

Salt Lake City, Utah, 84132, United States

Location

Aurora BayCare Medical Center

Green Bay, Wisconsin, 54311, United States

Location

MeSH Terms

Conditions

Low Back PainIntervertebral Disc Degeneration

Interventions

Total Disc Replacement

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSpinal DiseasesBone DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Study Officials

  • John J. Regan, MD

    Spine Source

    PRINCIPAL INVESTIGATOR
  • Christopher Bergin, MD

    Illinois Bone & Joint Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 7, 2007

First Posted

June 11, 2007

Study Start

January 1, 2007

Primary Completion

November 1, 2013

Study Completion

November 1, 2014

Last Updated

October 4, 2011

Record last verified: 2011-10

Locations